Dr. 15% more erythropoetin would cause a substantial increase in medications for an African American patient. Thats significant info considering that ESRD is usually secondary to Diabetes Mellitus and Hypertension clients who may have ESRD. I am African American,I suspect this treatment would deny patients with primary conditions that may lead to expensive treatments.
How would you modify this condition with a pre-existing condition and stay within the allowable cost containment?
Dr. 15% more erythropoetin would cause a substantial increase in medications for an African American patient. Thats significant info considering that ESRD is usually secondary to Diabetes Mellitus and Hypertension clients who may have ESRD. I am African American,I suspect this treatment would deny patients with primary conditions that may lead to expensive treatments.
How would you modify this condition with a pre-existing condition and stay within the allowable cost containment?
spacemanwalkth00 2 years ago